| Concord Drugs Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 538965 |
NSE Symbol : - |
P/E(TTM) : 151.85 |
|
ISIN Demat : INE858L01010 |
Div & Yield% : 0.00 |
EPS(TTM) : 0.54 |
|
Book Value(₹) : 34.42 |
Market Cap(₹Cr) : 82.00 |
Face Value(₹) : 10.00 |
| Particulars | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|
| Gross Sales | 10.07 | 13.38 | 7.96 | 10.77 | 11.84 | 6.35 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 10.07 | 13.38 | 7.96 | 10.77 | 11.84 | 6.35 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.00 |
| Total Income | 10.08 | 13.38 | 7.97 | 10.77 | 11.85 | 6.35 |
| Total Expenditure | 9.07 | 12.45 | 7.04 | 9.46 | 11.05 | 5.62 |
| PBIDT | 1.00 | 0.94 | 0.93 | 1.31 | 0.80 | 0.73 |
| Interest | 0.40 | 0.42 | 0.53 | 0.43 | 0.39 | 0.37 |
| PBDT | 0.61 | 0.52 | 0.40 | 0.89 | 0.41 | 0.36 |
| Depreciation | 0.34 | 0.37 | 0.37 | 0.37 | 0.34 | 0.34 |
| Tax | 0.08 | 0.05 | -0.01 | 0.14 | 0.03 | 0.02 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 0.00 | -0.01 | 0.02 | 0.16 | -0.01 | -0.01 |
| Reported Profit After Tax | 0.19 | 0.11 | 0.01 | 0.22 | 0.05 | 0.01 |
| Extra-ordinary Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | 0.19 | 0.11 | 0.01 | 0.22 | 0.05 | 0.01 |
| EPS (Unit Curr.) | 0.19 | 0.11 | 0.01 | 0.22 | 0.05 | 0.01 |
| EPS (Adj) (Unit Curr.) | 0.19 | 0.11 | 0.01 | 0.22 | 0.05 | 0.01 |
| Calculated EPS (Unit Curr.) | 0.19 | 0.11 | 0.01 | 0.22 | 0.05 | 0.01 |
| Calculated EPS (Adj) (Unit Curr.) | 0.19 | 0.11 | 0.01 | 0.22 | 0.05 | 0.01 |
| Calculated EPS (Ann.) (Unit Curr.) | 0.78 | 0.45 | 0.03 | 0.89 | 0.22 | 0.05 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 0.78 | 0.45 | 0.03 | 0.89 | 0.22 | 0.05 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Reserve & Surplus | 24.42 | 24.23 | 24.11 | 24.11 | 23.88 | 23.83 |
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 9.93 | 7.03 | 11.68 | 12.16 | 6.76 | 11.50 |
| PBDTM(%) | 6.06 | 3.89 | 5.03 | 8.26 | 3.46 | 5.67 |
| PATM(%) | 1.89 | 0.82 | 0.13 | 2.04 | 0.42 | 0.16 |